Log In
BCIQ
Print this Print this
 

ONT-10

  Manage Alerts
Collapse Summary General Information
Company Oncothyreon Inc.
DescriptionLiposomal glycolipopeptide cancer vaccine targeting mucin 1 (MUC1; CD227)
Molecular Target Mucin 1 (MUC1) (CD227)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today